To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
NCT00366366
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
Infanrix-Hexa
Sponsor
GlaxoSmithKline